David A. Campbell

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compositions and methods related to tumor activated antibodies targ...
- Patent number 12,161,724
- Issue date Dec 10, 2024
- JANUX THERAPEUTICS, INC.
- David Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Transglutaminase 2 (TG2) inhibitors
- Patent number 12,152,026
- Issue date Nov 26, 2024
- Sitari Pharma, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compositions and methods related to tumor activated antibodies targ...
- Patent number 11,555,078
- Issue date Jan 17, 2023
- JANUX THERAPEUTICS, INC.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Transglutaminase 2 (TG2) inhibitors
- Patent number 11,548,892
- Issue date Jan 10, 2023
- Sitari Pharma, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cleavable linker compositions and methods
- Patent number 11,512,113
- Issue date Nov 29, 2022
- JANUX THERAPEUTICS, INC.
- David Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Broad spectrum antibiotics
- Patent number 10,501,493
- Issue date Dec 10, 2019
- RQX Pharmaceuticals, Inc.
- Tucker Curran Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Linear peptide antibiotics
- Patent number 9,708,368
- Issue date Jul 18, 2017
- RQX Pharmaceuticals, Inc.
- Robert I. Higuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Macrocyclic broad spectrum antibiotics
- Patent number 9,309,285
- Issue date Apr 12, 2016
- RQX PHARMACEUTICALS, INC.
- Tucker Curran Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Linear peptide antibiotics
- Patent number 8,999,922
- Issue date Apr 7, 2015
- RQX Pharmaceuticals, Inc.
- Robert I. Higuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment...
- Patent number 8,912,203
- Issue date Dec 16, 2014
- Afraxis Holdings, Inc.
- David Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of C...
- Patent number 8,680,099
- Issue date Mar 25, 2014
- Afraxis Holdings, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds for treating neuropsychiatric conditions
- Patent number 8,674,095
- Issue date Mar 18, 2014
- Afraxis Holdings, Inc.
- David Campbell
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic boronic acid compounds
- Patent number 8,415,295
- Issue date Apr 9, 2013
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment...
- Patent number 8,372,970
- Issue date Feb 12, 2013
- Afraxis, Inc.
- Benedikt Vollrath
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Solid tartrate salts of DPP-IV inhibitors
- Patent number 8,299,271
- Issue date Oct 30, 2012
- Phenomix Corporation
- Zhen-Ping Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Activity-based probes and methods of their preparation and use
- Patent number 7,923,433
- Issue date Apr 12, 2011
- Activx Biosciences, Inc.
- David Winn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine compounds and methods for selective inhibition of dipep...
- Patent number 7,906,658
- Issue date Mar 15, 2011
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine compounds and methods for selective inhibition of dipep...
- Patent number 7,884,217
- Issue date Feb 8, 2011
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and methods for selective inhibition of dipeptidyl peptid...
- Patent number 7,825,139
- Issue date Nov 2, 2010
- Forest Laboratories Holdings Limited (BM)
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of preparing heterocyclic boronic acids and derivatives the...
- Patent number 7,786,312
- Issue date Aug 31, 2010
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Constrained cyano compounds
- Patent number 7,786,163
- Issue date Aug 31, 2010
- Forest Laboratories Holdings Limited (BM)
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methyl and ethyl substituted pyrrolidine compounds and methods for...
- Patent number 7,767,828
- Issue date Aug 3, 2010
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic boronic acid compounds
- Patent number 7,674,913
- Issue date Mar 9, 2010
- Phenomix Corporation
- David A. Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolidine compounds and methods for selective inhibition of dipep...
- Patent number 7,576,121
- Issue date Aug 18, 2009
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Acyl-nucleotide probes and methods of their synthesis and use in pr...
- Patent number 7,365,178
- Issue date Apr 29, 2008
- Activx Biosciences, Inc.
- David Alan Campbell
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Pyrrolidine compounds and methods for selective inhibition of dipep...
- Patent number 7,317,109
- Issue date Jan 8, 2008
- Phenomix Corporation
- David Alan Campbell
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS
- Publication number 20240376226
- Publication date Nov 14, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING EGFR AND CD3 AND USES THEREOF
- Publication number 20240254241
- Publication date Aug 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240252669
- Publication date Aug 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING TROP2 AND CD3 AND USES THEREOF
- Publication number 20240092931
- Publication date Mar 21, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240059790
- Publication date Feb 22, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS
- Publication number 20240043536
- Publication date Feb 8, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES TARGETING PSMA AND CD3 AND USES THEREOF
- Publication number 20240043565
- Publication date Feb 8, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HALF-LIFE EXTENDING COMPOSITIONS AND METHODS
- Publication number 20240034814
- Publication date Feb 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20240034806
- Publication date Feb 1, 2024
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS O...
- Publication number 20230406937
- Publication date Dec 21, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF
- Publication number 20230406955
- Publication date Dec 21, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF
- Publication number 20230357429
- Publication date Nov 9, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ACTIVATED MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-...
- Publication number 20230357447
- Publication date Nov 9, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20230348618
- Publication date Nov 2, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED ANTIBODIES
- Publication number 20230270854
- Publication date Aug 31, 2023
- Janux Therapeutics, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS
- Publication number 20230220109
- Publication date Jul 13, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUMOR ACTIVATED T CELL ENGAGERS AND METHODS OF USE THEREOF
- Publication number 20230220105
- Publication date Jul 13, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CLEAVABLE LINKER COMPOSITIONS AND METHODS
- Publication number 20230147782
- Publication date May 11, 2023
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...
- Publication number 20220177600
- Publication date Jun 9, 2022
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CLEAVABLE LINKER COMPOSITIONS AND METHODS
- Publication number 20220048949
- Publication date Feb 17, 2022
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORY T CELL RECEPTOR PEPTIDES AND DISCOVERY METHODS
- Publication number 20210371849
- Publication date Dec 2, 2021
- Janux Therapeutics, Inc.
- David CAMPBELL
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
TRANSGLUTAMINASE 2 (TG2) INHIBITORS
- Publication number 20210163480
- Publication date Jun 3, 2021
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED T CELL RECEPTORS
- Publication number 20210115106
- Publication date Apr 22, 2021
- Janux Therapeutics, Inc.
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED BISPECIFIC T CELL RECEPTORS
- Publication number 20200385440
- Publication date Dec 10, 2020
- Janux Therapeutics, Inc.
- David CAMPBELL
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MODIFIED ANTIBODIES
- Publication number 20180339043
- Publication date Nov 29, 2018
- Janux Therapeutics, Inc.
- David Campbell
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LINEAR PEPTIDE ANTIBIOTICS
- Publication number 20170275334
- Publication date Sep 28, 2017
- RQX PHARMACEUTICALS, INC.
- Robert I. Higuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DEUTERO-PHENFORMIN DERIVATIVES
- Publication number 20170210704
- Publication date Jul 27, 2017
- Enlibrium Inc
- David CAMPBELL
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BROAD SPECTRUM ANTIBIOTICS
- Publication number 20170073370
- Publication date Mar 16, 2017
- RQX PHARMACEUTICALS, INC.
- Tucker Curran Roberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LINEAR PEPTIDE ANTIBIOTICS
- Publication number 20150166605
- Publication date Jun 18, 2015
- RQX PHARMACEUTICALS, INC.
- Robert I. Higuchi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME
- Publication number 20150031693
- Publication date Jan 29, 2015
- Afraxis Holdings, Inc.
- John C. Mckew
- C07 - ORGANIC CHEMISTRY

David A. Campbell

Person

Patents Grantslast 30 patents

Compositions and methods related to tumor activated antibodies targ...

Transglutaminase 2 (TG2) inhibitors

Compositions and methods related to tumor activated antibodies targ...

Transglutaminase 2 (TG2) inhibitors

Cleavable linker compositions and methods

Broad spectrum antibiotics

Linear peptide antibiotics

Macrocyclic broad spectrum antibiotics

Linear peptide antibiotics

6-(sulfonylaryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment...

6-(ethynyl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment of C...

Compounds for treating neuropsychiatric conditions

Heterocyclic boronic acid compounds

8-ethyl-6-(aryl)pyrido[2,3-D]pyrimidin-7(8H)-ones for the treatment...

Solid tartrate salts of DPP-IV inhibitors

Activity-based probes and methods of their preparation and use

Pyrrolidine compounds and methods for selective inhibition of dipep...

Pyrrolidine compounds and methods for selective inhibition of dipep...

Compounds and methods for selective inhibition of dipeptidyl peptid...

Methods of preparing heterocyclic boronic acids and derivatives the...

Constrained cyano compounds

Methyl and ethyl substituted pyrrolidine compounds and methods for...

Heterocyclic boronic acid compounds

Pyrrolidine compounds and methods for selective inhibition of dipep...

Acyl-nucleotide probes and methods of their synthesis and use in pr...

Pyrrolidine compounds and methods for selective inhibition of dipep...

Patents Applicationslast 30 patents

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

ANTIBODIES TARGETING EGFR AND CD3 AND USES THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

ANTIBODIES TARGETING TROP2 AND CD3 AND USES THEREOF

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

PEPTIDE COMPOSITIONS AND METHODS FOR ANTI-CD3 BINDING DOMAINS

ANTIBODIES TARGETING PSMA AND CD3 AND USES THEREOF

HALF-LIFE EXTENDING COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-L1 AND METHODS O...

ANTIBODIES TARGETING HER2 AND CD3 AND USES THEREOF

OPTIMIZED ANTIBODIES TARGETING TROP2 AND USES THEREOF

TUMOR ACTIVATED MULTISPECIFIC ANTIBODIES FOR TARGETING CD28 AND PD-...

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

MODIFIED ANTIBODIES

COMPOSITIONS AND METHODS RELATING TO TUMOR ACTIVATED T CELL ENGAGERS

TUMOR ACTIVATED T CELL ENGAGERS AND METHODS OF USE THEREOF

CLEAVABLE LINKER COMPOSITIONS AND METHODS

COMPOSITIONS AND METHODS RELATED TO TUMOR ACTIVATED ANTIBODIES TARG...

CLEAVABLE LINKER COMPOSITIONS AND METHODS

INHIBITORY T CELL RECEPTOR PEPTIDES AND DISCOVERY METHODS

TRANSGLUTAMINASE 2 (TG2) INHIBITORS

MODIFIED T CELL RECEPTORS

MODIFIED BISPECIFIC T CELL RECEPTORS

MODIFIED ANTIBODIES

LINEAR PEPTIDE ANTIBIOTICS

DEUTERO-PHENFORMIN DERIVATIVES

BROAD SPECTRUM ANTIBIOTICS

LINEAR PEPTIDE ANTIBIOTICS

PAK INHIBITORS FOR THE TREATMENT OF FRAGILE X SYNDROME